High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology

We have established and efficient system to specify NG2/PDGF-Rα/OLIG2+ oligodendrocyte precursor cells (OPCs) from human embryonic stem cells (hESCs) at low, physiological (3%) oxygen levels. This was achieved via both forebrain and spinal cord origins, with up to 98% of cells expressing NG2. Develo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cell reports 2013-11, Vol.1 (5), p.437-450
Hauptverfasser: Stacpoole, Sybil R.L., Spitzer, Sonia, Bilican, Bilada, Compston, Alastair, Karadottir, Ragnhildur, Chandran, Siddharthan, Franklin, Robin J.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 450
container_issue 5
container_start_page 437
container_title Stem cell reports
container_volume 1
creator Stacpoole, Sybil R.L.
Spitzer, Sonia
Bilican, Bilada
Compston, Alastair
Karadottir, Ragnhildur
Chandran, Siddharthan
Franklin, Robin J.M.
description We have established and efficient system to specify NG2/PDGF-Rα/OLIG2+ oligodendrocyte precursor cells (OPCs) from human embryonic stem cells (hESCs) at low, physiological (3%) oxygen levels. This was achieved via both forebrain and spinal cord origins, with up to 98% of cells expressing NG2. Developmental insights reveal a critical role for fibroblast growth factor 2 (FGF-2) in OLIG2 induction via ventral forebrain pathways. The OPCs mature in vitro to express O4 (46%) and subsequently become galactocerebroside (GALC), O1, and myelin basic protein-positive (MBP+) multibranching oligodendrocytes. These were cultured alongside hESC-derived neurons. The electrophysiological properties of human OPCs are similar to those of rat OPCs, with large voltage-gated sodium currents and the ability to fire action potentials. Exposure to a selective retinoid X receptor agonist increased the proportion of O4+ oligodendrocytes that express MBP from 5% to 30%. Thus, we have established a developmentally engineered system to investigate the biological properties of human OPCs and test the effects of putative remyelinating agents prior to clinical application. •Human OPCs and oligodendrocytes can be generated at physiological (3%) O2 tensions•hESC-derived OPCs can be specified via both spinal cord and ventral forebrain origins•Human OPCs have large voltage-gated sodium currents and can fire action potentials•RXR signaling is a relevant target for remyelinating therapies in humans Stacpoole and colleagues established a system to specify human oligodendrocyte precursor cells (OPCs) and multibranching oligodendrocytes from embryonic stem cells at physiological (3%) oxygen, from both forebrain and spinal cord. These human OPCs can fire action potentials and respond to retinoid X receptor agonists, demonstrating the usefulness of this developmentally engineered system as a translational resource.
doi_str_mv 10.1016/j.stemcr.2013.09.006
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3841262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213671113000933</els_id><sourcerecordid>1469205717</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-3d2f4cbde2df5de9bcb2adeaa3cccb49ff0622fbd1d4b63bc82e1c64ed661ca53</originalsourceid><addsrcrecordid>eNp9UU2P0zAQjRCIXS37DxDykUuD7bhuc0GCqlCkSkWiHDhZzniSunLsxU6rzQ_h_-Juy7Jc8MWej_feeF5RvGa0ZJTJd_syDdhDLDllVUnrklL5rLjmnFUTOWPs-ZP3VXGb0p7mU9eMC_ayuOKCzyWt2HXxa2W7Hflh0ZlEQks2znbBoDcxwDggWVuPukOyQOcSaWPoyerQa0-WfRPH4C2Qb3mSS10P5OtuTDa40FnQjmzuxw492aLPSZ8JQiTLo3YHPeT4JLiN2if3EOb-jw_Q8VXxotUu4e3lvim-f1puF6vJevP5y-LDegJCVsOkMrwV0Bjkpp0arBtouDaodQUAjajblkrO28YwIxpZNTDnyEAKNFIy0NPqpnh_5r07ND0aQD9E7dRdtL2Oowraqn8r3u5UF46qmgvGJc8Eby8EMfw8YBpUbxPkXWiP4ZAUE7LmdDpjs9wqzq0QQ0oR20cZRtXJVLVXZ1PVyVRFa5VNzbA3T0d8BP2x8O8fMC_qaDGqBBY9oLERYVAm2P8r_Aa3nbr7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1469205717</pqid></control><display><type>article</type><title>High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Stacpoole, Sybil R.L. ; Spitzer, Sonia ; Bilican, Bilada ; Compston, Alastair ; Karadottir, Ragnhildur ; Chandran, Siddharthan ; Franklin, Robin J.M.</creator><creatorcontrib>Stacpoole, Sybil R.L. ; Spitzer, Sonia ; Bilican, Bilada ; Compston, Alastair ; Karadottir, Ragnhildur ; Chandran, Siddharthan ; Franklin, Robin J.M.</creatorcontrib><description>We have established and efficient system to specify NG2/PDGF-Rα/OLIG2+ oligodendrocyte precursor cells (OPCs) from human embryonic stem cells (hESCs) at low, physiological (3%) oxygen levels. This was achieved via both forebrain and spinal cord origins, with up to 98% of cells expressing NG2. Developmental insights reveal a critical role for fibroblast growth factor 2 (FGF-2) in OLIG2 induction via ventral forebrain pathways. The OPCs mature in vitro to express O4 (46%) and subsequently become galactocerebroside (GALC), O1, and myelin basic protein-positive (MBP+) multibranching oligodendrocytes. These were cultured alongside hESC-derived neurons. The electrophysiological properties of human OPCs are similar to those of rat OPCs, with large voltage-gated sodium currents and the ability to fire action potentials. Exposure to a selective retinoid X receptor agonist increased the proportion of O4+ oligodendrocytes that express MBP from 5% to 30%. Thus, we have established a developmentally engineered system to investigate the biological properties of human OPCs and test the effects of putative remyelinating agents prior to clinical application. •Human OPCs and oligodendrocytes can be generated at physiological (3%) O2 tensions•hESC-derived OPCs can be specified via both spinal cord and ventral forebrain origins•Human OPCs have large voltage-gated sodium currents and can fire action potentials•RXR signaling is a relevant target for remyelinating therapies in humans Stacpoole and colleagues established a system to specify human oligodendrocyte precursor cells (OPCs) and multibranching oligodendrocytes from embryonic stem cells at physiological (3%) oxygen, from both forebrain and spinal cord. These human OPCs can fire action potentials and respond to retinoid X receptor agonists, demonstrating the usefulness of this developmentally engineered system as a translational resource.</description><identifier>ISSN: 2213-6711</identifier><identifier>EISSN: 2213-6711</identifier><identifier>DOI: 10.1016/j.stemcr.2013.09.006</identifier><identifier>PMID: 24286031</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Action Potentials ; Basic Helix-Loop-Helix Transcription Factors - genetics ; Basic Helix-Loop-Helix Transcription Factors - metabolism ; Cell Lineage ; Cells, Cultured ; Embryonic Stem Cells - cytology ; Embryonic Stem Cells - drug effects ; Embryonic Stem Cells - metabolism ; Fibroblast Growth Factor 2 - pharmacology ; Galactosylceramides - metabolism ; Humans ; Myelin Basic Protein - genetics ; Myelin Basic Protein - metabolism ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - metabolism ; Neural Stem Cells - cytology ; Neural Stem Cells - drug effects ; Neural Stem Cells - metabolism ; Neural Stem Cells - physiology ; Neurogenesis ; Oligodendrocyte Transcription Factor 2 ; Oligodendroglia - cytology ; Oligodendroglia - drug effects ; Oligodendroglia - metabolism ; Oligodendroglia - physiology ; Oxygen - pharmacology ; Prosencephalon - cytology ; Retinoid X Receptors - antagonists &amp; inhibitors ; Sodium - metabolism ; Spinal Cord - cytology</subject><ispartof>Stem cell reports, 2013-11, Vol.1 (5), p.437-450</ispartof><rights>2013 The Authors</rights><rights>2013 The Authors 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-3d2f4cbde2df5de9bcb2adeaa3cccb49ff0622fbd1d4b63bc82e1c64ed661ca53</citedby><cites>FETCH-LOGICAL-c463t-3d2f4cbde2df5de9bcb2adeaa3cccb49ff0622fbd1d4b63bc82e1c64ed661ca53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841262/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841262/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24286031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stacpoole, Sybil R.L.</creatorcontrib><creatorcontrib>Spitzer, Sonia</creatorcontrib><creatorcontrib>Bilican, Bilada</creatorcontrib><creatorcontrib>Compston, Alastair</creatorcontrib><creatorcontrib>Karadottir, Ragnhildur</creatorcontrib><creatorcontrib>Chandran, Siddharthan</creatorcontrib><creatorcontrib>Franklin, Robin J.M.</creatorcontrib><title>High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology</title><title>Stem cell reports</title><addtitle>Stem Cell Reports</addtitle><description>We have established and efficient system to specify NG2/PDGF-Rα/OLIG2+ oligodendrocyte precursor cells (OPCs) from human embryonic stem cells (hESCs) at low, physiological (3%) oxygen levels. This was achieved via both forebrain and spinal cord origins, with up to 98% of cells expressing NG2. Developmental insights reveal a critical role for fibroblast growth factor 2 (FGF-2) in OLIG2 induction via ventral forebrain pathways. The OPCs mature in vitro to express O4 (46%) and subsequently become galactocerebroside (GALC), O1, and myelin basic protein-positive (MBP+) multibranching oligodendrocytes. These were cultured alongside hESC-derived neurons. The electrophysiological properties of human OPCs are similar to those of rat OPCs, with large voltage-gated sodium currents and the ability to fire action potentials. Exposure to a selective retinoid X receptor agonist increased the proportion of O4+ oligodendrocytes that express MBP from 5% to 30%. Thus, we have established a developmentally engineered system to investigate the biological properties of human OPCs and test the effects of putative remyelinating agents prior to clinical application. •Human OPCs and oligodendrocytes can be generated at physiological (3%) O2 tensions•hESC-derived OPCs can be specified via both spinal cord and ventral forebrain origins•Human OPCs have large voltage-gated sodium currents and can fire action potentials•RXR signaling is a relevant target for remyelinating therapies in humans Stacpoole and colleagues established a system to specify human oligodendrocyte precursor cells (OPCs) and multibranching oligodendrocytes from embryonic stem cells at physiological (3%) oxygen, from both forebrain and spinal cord. These human OPCs can fire action potentials and respond to retinoid X receptor agonists, demonstrating the usefulness of this developmentally engineered system as a translational resource.</description><subject>Action Potentials</subject><subject>Basic Helix-Loop-Helix Transcription Factors - genetics</subject><subject>Basic Helix-Loop-Helix Transcription Factors - metabolism</subject><subject>Cell Lineage</subject><subject>Cells, Cultured</subject><subject>Embryonic Stem Cells - cytology</subject><subject>Embryonic Stem Cells - drug effects</subject><subject>Embryonic Stem Cells - metabolism</subject><subject>Fibroblast Growth Factor 2 - pharmacology</subject><subject>Galactosylceramides - metabolism</subject><subject>Humans</subject><subject>Myelin Basic Protein - genetics</subject><subject>Myelin Basic Protein - metabolism</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Neural Stem Cells - cytology</subject><subject>Neural Stem Cells - drug effects</subject><subject>Neural Stem Cells - metabolism</subject><subject>Neural Stem Cells - physiology</subject><subject>Neurogenesis</subject><subject>Oligodendrocyte Transcription Factor 2</subject><subject>Oligodendroglia - cytology</subject><subject>Oligodendroglia - drug effects</subject><subject>Oligodendroglia - metabolism</subject><subject>Oligodendroglia - physiology</subject><subject>Oxygen - pharmacology</subject><subject>Prosencephalon - cytology</subject><subject>Retinoid X Receptors - antagonists &amp; inhibitors</subject><subject>Sodium - metabolism</subject><subject>Spinal Cord - cytology</subject><issn>2213-6711</issn><issn>2213-6711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU2P0zAQjRCIXS37DxDykUuD7bhuc0GCqlCkSkWiHDhZzniSunLsxU6rzQ_h_-Juy7Jc8MWej_feeF5RvGa0ZJTJd_syDdhDLDllVUnrklL5rLjmnFUTOWPs-ZP3VXGb0p7mU9eMC_ayuOKCzyWt2HXxa2W7Hflh0ZlEQks2znbBoDcxwDggWVuPukOyQOcSaWPoyerQa0-WfRPH4C2Qb3mSS10P5OtuTDa40FnQjmzuxw492aLPSZ8JQiTLo3YHPeT4JLiN2if3EOb-jw_Q8VXxotUu4e3lvim-f1puF6vJevP5y-LDegJCVsOkMrwV0Bjkpp0arBtouDaodQUAjajblkrO28YwIxpZNTDnyEAKNFIy0NPqpnh_5r07ND0aQD9E7dRdtL2Oowraqn8r3u5UF46qmgvGJc8Eby8EMfw8YBpUbxPkXWiP4ZAUE7LmdDpjs9wqzq0QQ0oR20cZRtXJVLVXZ1PVyVRFa5VNzbA3T0d8BP2x8O8fMC_qaDGqBBY9oLERYVAm2P8r_Aa3nbr7</recordid><startdate>20131119</startdate><enddate>20131119</enddate><creator>Stacpoole, Sybil R.L.</creator><creator>Spitzer, Sonia</creator><creator>Bilican, Bilada</creator><creator>Compston, Alastair</creator><creator>Karadottir, Ragnhildur</creator><creator>Chandran, Siddharthan</creator><creator>Franklin, Robin J.M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131119</creationdate><title>High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology</title><author>Stacpoole, Sybil R.L. ; Spitzer, Sonia ; Bilican, Bilada ; Compston, Alastair ; Karadottir, Ragnhildur ; Chandran, Siddharthan ; Franklin, Robin J.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-3d2f4cbde2df5de9bcb2adeaa3cccb49ff0622fbd1d4b63bc82e1c64ed661ca53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Action Potentials</topic><topic>Basic Helix-Loop-Helix Transcription Factors - genetics</topic><topic>Basic Helix-Loop-Helix Transcription Factors - metabolism</topic><topic>Cell Lineage</topic><topic>Cells, Cultured</topic><topic>Embryonic Stem Cells - cytology</topic><topic>Embryonic Stem Cells - drug effects</topic><topic>Embryonic Stem Cells - metabolism</topic><topic>Fibroblast Growth Factor 2 - pharmacology</topic><topic>Galactosylceramides - metabolism</topic><topic>Humans</topic><topic>Myelin Basic Protein - genetics</topic><topic>Myelin Basic Protein - metabolism</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Neural Stem Cells - cytology</topic><topic>Neural Stem Cells - drug effects</topic><topic>Neural Stem Cells - metabolism</topic><topic>Neural Stem Cells - physiology</topic><topic>Neurogenesis</topic><topic>Oligodendrocyte Transcription Factor 2</topic><topic>Oligodendroglia - cytology</topic><topic>Oligodendroglia - drug effects</topic><topic>Oligodendroglia - metabolism</topic><topic>Oligodendroglia - physiology</topic><topic>Oxygen - pharmacology</topic><topic>Prosencephalon - cytology</topic><topic>Retinoid X Receptors - antagonists &amp; inhibitors</topic><topic>Sodium - metabolism</topic><topic>Spinal Cord - cytology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stacpoole, Sybil R.L.</creatorcontrib><creatorcontrib>Spitzer, Sonia</creatorcontrib><creatorcontrib>Bilican, Bilada</creatorcontrib><creatorcontrib>Compston, Alastair</creatorcontrib><creatorcontrib>Karadottir, Ragnhildur</creatorcontrib><creatorcontrib>Chandran, Siddharthan</creatorcontrib><creatorcontrib>Franklin, Robin J.M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Stem cell reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stacpoole, Sybil R.L.</au><au>Spitzer, Sonia</au><au>Bilican, Bilada</au><au>Compston, Alastair</au><au>Karadottir, Ragnhildur</au><au>Chandran, Siddharthan</au><au>Franklin, Robin J.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology</atitle><jtitle>Stem cell reports</jtitle><addtitle>Stem Cell Reports</addtitle><date>2013-11-19</date><risdate>2013</risdate><volume>1</volume><issue>5</issue><spage>437</spage><epage>450</epage><pages>437-450</pages><issn>2213-6711</issn><eissn>2213-6711</eissn><abstract>We have established and efficient system to specify NG2/PDGF-Rα/OLIG2+ oligodendrocyte precursor cells (OPCs) from human embryonic stem cells (hESCs) at low, physiological (3%) oxygen levels. This was achieved via both forebrain and spinal cord origins, with up to 98% of cells expressing NG2. Developmental insights reveal a critical role for fibroblast growth factor 2 (FGF-2) in OLIG2 induction via ventral forebrain pathways. The OPCs mature in vitro to express O4 (46%) and subsequently become galactocerebroside (GALC), O1, and myelin basic protein-positive (MBP+) multibranching oligodendrocytes. These were cultured alongside hESC-derived neurons. The electrophysiological properties of human OPCs are similar to those of rat OPCs, with large voltage-gated sodium currents and the ability to fire action potentials. Exposure to a selective retinoid X receptor agonist increased the proportion of O4+ oligodendrocytes that express MBP from 5% to 30%. Thus, we have established a developmentally engineered system to investigate the biological properties of human OPCs and test the effects of putative remyelinating agents prior to clinical application. •Human OPCs and oligodendrocytes can be generated at physiological (3%) O2 tensions•hESC-derived OPCs can be specified via both spinal cord and ventral forebrain origins•Human OPCs have large voltage-gated sodium currents and can fire action potentials•RXR signaling is a relevant target for remyelinating therapies in humans Stacpoole and colleagues established a system to specify human oligodendrocyte precursor cells (OPCs) and multibranching oligodendrocytes from embryonic stem cells at physiological (3%) oxygen, from both forebrain and spinal cord. These human OPCs can fire action potentials and respond to retinoid X receptor agonists, demonstrating the usefulness of this developmentally engineered system as a translational resource.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24286031</pmid><doi>10.1016/j.stemcr.2013.09.006</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2213-6711
ispartof Stem cell reports, 2013-11, Vol.1 (5), p.437-450
issn 2213-6711
2213-6711
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3841262
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Action Potentials
Basic Helix-Loop-Helix Transcription Factors - genetics
Basic Helix-Loop-Helix Transcription Factors - metabolism
Cell Lineage
Cells, Cultured
Embryonic Stem Cells - cytology
Embryonic Stem Cells - drug effects
Embryonic Stem Cells - metabolism
Fibroblast Growth Factor 2 - pharmacology
Galactosylceramides - metabolism
Humans
Myelin Basic Protein - genetics
Myelin Basic Protein - metabolism
Nerve Tissue Proteins - genetics
Nerve Tissue Proteins - metabolism
Neural Stem Cells - cytology
Neural Stem Cells - drug effects
Neural Stem Cells - metabolism
Neural Stem Cells - physiology
Neurogenesis
Oligodendrocyte Transcription Factor 2
Oligodendroglia - cytology
Oligodendroglia - drug effects
Oligodendroglia - metabolism
Oligodendroglia - physiology
Oxygen - pharmacology
Prosencephalon - cytology
Retinoid X Receptors - antagonists & inhibitors
Sodium - metabolism
Spinal Cord - cytology
title High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational Biology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A27%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20Yields%20of%20Oligodendrocyte%20Lineage%20Cells%20from%20Human%20Embryonic%20Stem%20Cells%20at%20Physiological%20Oxygen%20Tensions%20for%20Evaluation%20of%20Translational%20Biology&rft.jtitle=Stem%20cell%20reports&rft.au=Stacpoole,%20Sybil%C2%A0R.L.&rft.date=2013-11-19&rft.volume=1&rft.issue=5&rft.spage=437&rft.epage=450&rft.pages=437-450&rft.issn=2213-6711&rft.eissn=2213-6711&rft_id=info:doi/10.1016/j.stemcr.2013.09.006&rft_dat=%3Cproquest_pubme%3E1469205717%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1469205717&rft_id=info:pmid/24286031&rft_els_id=S2213671113000933&rfr_iscdi=true